The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Soluble urokinase-type plasminogen activator receptor, suPAR, as a prognostic biomarker in advanced pancreatic cancer.
 
Rikke Løvendahl Eefsen
Consulting or Advisory Role - Amgen
Research Funding - Bristol-Myers Squibb/Medarex (Inst)
 
Ib Jarle Christensen
No Relationships to Disclose
 
Dan Calatyud
Employment - Nanovi
Leadership - Nanovi
Stock and Other Ownership Interests - Ambu; Lundbeck; Nanovi
 
Astrid Zedlitz Johansen
No Relationships to Disclose
 
Inna Markovna Chen
Consulting or Advisory Role - Amgen; AstraZeneca
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genis (Inst); Roche (Inst); Varian Medical Systems (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Celgene; Roche
 
Louise Skau Rasmussen
No Relationships to Disclose
 
Per Pfeiffer
No Relationships to Disclose
 
Niels Henrik Hollander
No Relationships to Disclose
 
Fahimeh Andersen
No Relationships to Disclose
 
Julia S. Johansen
No Relationships to Disclose
 
Gunilla Hoyer-Hansen
No Relationships to Disclose